Medicare Enrolled

Dr. Mehmet Hepgur, MD

Hematology & Oncology · Deerfield Beach, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
201 E SAMPLE RD, Deerfield Beach, FL 33064
9547866460
In practice since 2006 (19 years)
NPI: 1053355701 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hepgur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hepgur? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hepgur

Dr. Mehmet Hepgur is a hematology & oncology specialist in Deerfield Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hepgur performed 1,225 Medicare services across 590 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hepgur received a total of $9,842 from 59 pharmaceutical and/or device companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hepgur is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in FL $9,842 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,225
Medicare services
Top 37% in FL for hematology & oncology
590
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~64 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 422 $73 $401
Hospital follow-up visit, low complexity 397 $42 $209
Initial hospital admission, moderate complexity 191 $108 $541
Hospital follow-up visit, moderate complexity 79 $65 $330
Office visit, established patient (20-29 min) 47 $44 $272
Office visit, established patient, complex (40-54 min) 43 $109 $587
New patient office visit (45-59 min) 20 $111 $550
Hospital follow-up visit, high complexity 14 $98 $493
New patient office visit, complex (60-74 min) 12 $130 $752
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,842
Total received (2018-2024)
Avg $1,406/year across 7 years
Top 37% in FL for hematology & oncology
59
Companies
416
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,150 (93.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$692 (7.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,187
2023
$2,627
2022
$2,107
2021
$721
2020
$72
2019
$201
2018
$927

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$1,035
PFIZER INC.
$914
Janssen Biotech, Inc.
$883
Novartis Pharmaceuticals Corporation
$641
Merck Sharp & Dohme LLC
$465
E.R. Squibb & Sons, L.L.C.
$449
AstraZeneca Pharmaceuticals LP
$427
Celgene Corporation
$375
Incyte Corporation
$355
Astellas Pharma US Inc
$341
Seagen Inc.
$308
Genentech USA, Inc.
$284
Rigel Pharmaceuticals, Inc.
$271
GlaxoSmithKline, LLC.
$247
Sirtex Medical Inc
$238
EMD Serono, Inc.
$197
GENZYME CORPORATION
$184
Lilly USA, LLC
$163
Regeneron Healthcare Solutions, Inc.
$146
ImmunoGen, Inc.
$133
ARRAY BIOPHARMA INC
$125
Amgen Inc.
$122
Takeda Pharmaceuticals U.S.A., Inc.
$107
SEAGEN INC.
$100
Alexion Pharmaceuticals, Inc.
$96
SOBI, INC
$71
Eisai Inc.
$71
Janssen Pharmaceuticals, Inc
$68
Karyopharm Therapeutics Inc.
$67
Gilead Sciences, Inc.
$61
Sobi, Inc
$58
PUMA BIOTECHNOLOGY, INC.
$55
Pharmacyclics LLC, An AbbVie Company
$50
EISAI INC.
$48
Daiichi Sankyo Inc.
$48
ABBVIE INC.
$46
Aurobindo Pharma USA, Inc.
$44
MEDIVATION FIELD SOLUTIONS LLC
$44
RECORDATI_RARE_DISEASES_INC.
$43
Bayer Healthcare Pharmaceuticals Inc.
$43
Puma Biotechnology, Inc.
$43
Merck Sharp & Dohme Corporation
$35
Amneal Pharmaceuticals LLC
$29
Pharmacosmos Therapeutics Inc.
$29
Mirati Therapeutics, Inc.
$27
Myovant Sciences Inc.
$24
Ipsen Biopharmaceuticals, Inc
$24
TerSera Therapeutics LLC
$23
TG Therapeutics, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$21
TG THERAPEUTICS, INC.
$21
BeiGene USA, Inc.
$19
Emmaus Medical, Inc.
$18
Lexicon Pharmaceuticals, Inc.
$17
Myriad Genetic Laboratories, Inc.
$16
Seattle Genetics, Inc.
$15
Exelixis Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Dova Pharmaceuticals
$12
Top 3 companies account for 28.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · CERDELGA · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ERLEADA · Elahere · Endari · Enhertu · FLOWTRIEVER CATHETER · Fabhalta · Folotyn · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · PreciseTumor · REBLOZYL · RELEUKO · RYBREVANT · Revlimid · Rezlidhia · S · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · ZEJULA · ZOLADEX · ZYKADIA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $803 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Deerfield Beach?
Compare hematology & oncology specialists in the Deerfield Beach area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
116
Per 100K population
6.0
County median income
$74,534
Nearest hospital
BROWARD HEALTH NORTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hepgur is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hepgur experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hepgur performed 422 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hepgur receive payments from pharmaceutical companies?
Yes. Dr. Hepgur received a total of $9,842 from 59 companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hepgur's costs compare to other hematology & oncology specialists in Deerfield Beach?
Dr. Hepgur's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hepgur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →